On March 23, 2022, the full range of clean area protective wearable equipment provided by Jiabo Litong for Sinopharm Zhongsheng & G42 UAE New Crown Vaccine Project was successfully delivered.

The project is implemented and executed by the life science joint venture jointly established by Sinopharm Group China Biotechnology and the United Arab Emirates G42 Group. The company has 3 filling lines and 5 automatic packaging lines, and the annual production capacity of the vaccine will reach 200 million doses. This is the first new crown vaccine in the UAE, which will provide a reliable vaccine guarantee for the Middle East and Africa region and play a crucial role in defeating the epidemic in the Middle East and Africa region.

After receiving the order inquiry, Jiabo Litong responded quickly, actively formulated a reasonable configuration plan, won the recognition of users with professional knowledge, dedicated attitude and dedicated service, and stood out among many excellent domestic competitors.
After the Spring Festival, user orders surged. With the increasingly severe epidemic prevention and control situation in Shanghai, the company's production pressure increased sharply.

The delivery date of Sinopharm Zhongsheng & G42 UAE new crown vaccine project is imminent. In order to ensure the on-time delivery and the normal production and supply of anti-epidemic materials in Shanghai, more than 70 front-line production personnel from Jiabo Litong have settled in the factory. Work overtime to produce orders and epidemic prevention materials.
In the production process, the people of Jiabo 's  have overcome the severe challenges of tight time, heavy tasks, high requirements and high pressure, and completed the tasks with high quality and quantity. brand and image.

The successful implementation of Sinopharm Zhongsheng & G42 UAE new crown vaccine project reflects the international competitiveness of China's vaccines, and at the same time reflects China's responsibility as a major country. Using the UAE as a platform, Chinese vaccines can benefit people in more regions and make an important contribution to global cooperation in fighting the epidemic. contribute.
As the only Chinese supplier of protective wearable equipment in the clean area of the project, Jiabo Litong's general strength has confirmed the reliability and international competitiveness of the product.
The smooth delivery of this project is an important milestone for Jiabo Litong to help the global fight against the epidemic, and it is a new starting point for Jiabo Litong to go international. Set sail and go to the sea of stars. Jiabo Litong will continue to uphold its original aspirations, demonstrate corporate responsibility and responsibility, take protecting people's lives, health and safety as its own responsibility, and make a modest contribution to the global fight against the epidemic.